PT862462E - Uma nova combinacao de um bloqueador de receptores beta e de um opioide - Google Patents

Uma nova combinacao de um bloqueador de receptores beta e de um opioide

Info

Publication number
PT862462E
PT862462E PT96933709T PT96933709T PT862462E PT 862462 E PT862462 E PT 862462E PT 96933709 T PT96933709 T PT 96933709T PT 96933709 T PT96933709 T PT 96933709T PT 862462 E PT862462 E PT 862462E
Authority
PT
Portugal
Prior art keywords
pct
opioid
receptor blocker
new combination
pharmaceutically acceptable
Prior art date
Application number
PT96933709T
Other languages
English (en)
Inventor
Arne Eek
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT862462E publication Critical patent/PT862462E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medicines Containing Plant Substances (AREA)
PT96933709T 1995-10-06 1996-10-03 Uma nova combinacao de um bloqueador de receptores beta e de um opioide PT862462E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9503476A SE9503476D0 (sv) 1995-10-06 1995-10-06 New combination

Publications (1)

Publication Number Publication Date
PT862462E true PT862462E (pt) 2004-06-30

Family

ID=20399727

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96933709T PT862462E (pt) 1995-10-06 1996-10-03 Uma nova combinacao de um bloqueador de receptores beta e de um opioide

Country Status (14)

Country Link
US (1) US5908847A (pt)
EP (1) EP0862462B1 (pt)
JP (1) JP4135977B2 (pt)
AT (1) ATE259657T1 (pt)
AU (1) AU706794B2 (pt)
CA (1) CA2233677C (pt)
DE (1) DE69631597T2 (pt)
DK (1) DK0862462T3 (pt)
ES (1) ES2214548T3 (pt)
NO (1) NO318387B1 (pt)
NZ (1) NZ319746A (pt)
PT (1) PT862462E (pt)
SE (1) SE9503476D0 (pt)
WO (1) WO1997012634A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100306707B1 (ko) * 1998-09-07 2003-01-24 한국전기통신공사 교차이득변조형반도체광파장변환기
US7041365B2 (en) * 2003-05-12 2006-05-09 3M Innovative Properties Company Static dissipative optical construction
US8716350B2 (en) 2010-03-30 2014-05-06 Algynomics Inc. Compositions and methods for the treatment of somatosensory disorders
JP2013523764A (ja) * 2010-03-30 2013-06-17 アルジーノミクス インコーポレイテッド 体性感覚障害治療用の組成物と方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities

Also Published As

Publication number Publication date
ATE259657T1 (de) 2004-03-15
EP0862462A1 (en) 1998-09-09
JPH11513386A (ja) 1999-11-16
NO318387B1 (no) 2005-03-14
DK0862462T3 (da) 2004-05-10
JP4135977B2 (ja) 2008-08-20
ES2214548T3 (es) 2004-09-16
AU7233596A (en) 1997-04-28
EP0862462B1 (en) 2004-02-18
US5908847A (en) 1999-06-01
NZ319746A (en) 1999-11-29
DE69631597T2 (de) 2004-12-16
WO1997012634A1 (en) 1997-04-10
CA2233677C (en) 2006-08-29
AU706794B2 (en) 1999-06-24
CA2233677A1 (en) 1997-04-10
NO981222L (no) 1998-03-18
NO981222D0 (no) 1998-03-18
SE9503476D0 (sv) 1995-10-06
DE69631597D1 (de) 2004-03-25

Similar Documents

Publication Publication Date Title
HU9203779D0 (en) (+)-alpha-(2,3-dimethoxi-phenyl)-1-[2-(4-fluoric-phenyl)-ethyl]-4-piperidine-methanole
ATE218854T1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
PL309596A1 (en) Application of anticonvulsant agents in treating parkinson disease and parkinsonian syndromes
WO1998026770A3 (en) The topical use of kappa opioid agonists to treat ocular pain
GB2274777B (en) Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors
PT862462E (pt) Uma nova combinacao de um bloqueador de receptores beta e de um opioide
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
GB9802542D0 (en) New use
ES2157984T3 (es) Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis.
HK1046847A1 (en) Pharmaceutical combination with analgesic action containing paracetamol and buspirone.
IL126158A0 (en) Method for treating substance abuse
CA2341891A1 (en) The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
IL108283A0 (en) Use of riluzole for promoting restoration following radiation
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
BG100479U (en) Medicament for the local treatment of otitis